Jasper Therapeutics, Inc.

Amplitude Healthcare Acquisition Corporation, trading under the ticker AMHC, was a blank-check company that completed its initial public offering in 2021 with a focus on the healthcare and biopharmaceutical sector. Sponsored by Amplitude Healthcare Partners, the SPAC filed an 8-K with the SEC on September 29, 2021, in connection with its proposed business combination with Jasper Therapeutics, Inc., a clinical-stage biopharmaceutical company developing antibody-based conditioning therapies for hematopoietic stem cell transplantation. The filing reflects the de-SPAC process as the combined entity moved toward completing its merger and transitioning Jasper Therapeutics into a publicly listed company. Sign up at SpacDesk for full filing history, deal timelines, and sponsor data on AMHC and hundreds of other SPAC transactions.